Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|July 22, 2017
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction modelAndrea Driscoll, Elizabeth H Barnes, Stefan Blankenberg, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Neuro-Oncology Practice|August 7, 2019
Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trialElizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, et al.
Epilepsy & Behavior Reports|July 28, 2022
Predictors of longitudinal seizure outcomes after epilepsy surgery in childhoodAmy Ka, Amir Taher, Stephanie D'Souza, et al.
Cancer|July 6, 2017
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Kathryn M Field, Pramit M Phal, Greg Fitt, et al.
Plos One|August 31, 2016
Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral EncephalitisKavitha Kothur, Louise Wienholt, Shekeeb S Mohammad, et al.
Molecular Genetics and Metabolism|January 7, 2022
FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in childrenLisa G Riley, Michael Nafisinia, Minal J Menezes, et al.
Asia-Pacific Journal of Clinical Oncology|November 9, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trialKathryn M Field, Greg Fitt, Mark A Rosenthal, et al.
BMJ Open|January 4, 2023
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trialAmeneh Khatami, David A Foley, Morgyn S Warner, et al.
Neuro-Oncology|July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastomaKathryn M Field, John Simes, Anna K Nowak, et al.
Pageof 7